drugset / Trial / NCT00902746

Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With Endometriosis

NCT00902746

Phase 3 Completed 149 enrolled Nobelpharma
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this long-term study is to determine whether NPC-01 is effective in the treatment of dysmenorrhea associated with endometriosis.

Timeline

Start
2009-05
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Norethindrone Unknown 0.6 mg
Subject Norethindrone Unknown 1 mg
Subject ethinyl estradiol Small molecule 0.035 mg

Indications